OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
AYUPA$63.1157

Australian Unity Ltd

Healthcare Facilities & ServicesVerified

Australian Unity has a market capitalization of $485.54 million and a price-to-earnings ratio of 18.28, indicating a moderate valuation relative to its earnings. The company's price-to-book ratio is 0.39, suggesting that its market value is significantly lower than its book value. The enterprise value to EBITDA ratio is 3.46, which is relatively low compared to industry norms, potentially indicating undervaluation or weak earnings power. In terms of profitability, Australian Unity's return on equity is 2.14%, and its return on assets is 0.25%, both of which are below the industry median for healthcare facilities and services. The company's operating income is $188.16 million, but its net income is only $26.56 million, indicating high operating expenses or significant non-operating costs. The debt-to-equity ratio is 0.54, which is relatively low, suggesting a conservative capital structure. The company's revenue is distributed across four segments: Home Health, Insurances, Residential Aged Care, and Wealth & Capital Markets. The Home Health segment provides home care and health services, while the Insurances segment offers private health insurance and distributes general insurance products. The Residential Aged Care segment owns and operates aged care facilities, and the Wealth & Capital Markets segment manages investment funds and provides trustee services. The geographic exposure is primarily within Australia, with no significant international operations disclosed. Australian Unity's growth trajectory is modest, with no significant revenue growth reported in the latest financial period. The company's capital expenditure is negative at $83.58 million, indicating asset disposals or a reduction in capital spending. The free cash flow is also negative at $6.74 million, suggesting that the company is not generating sufficient cash from operations to cover its capital expenditures. The outlook for the next fiscal year is uncertain, with no clear direction provided in the financial data. The company faces medium liquidity risk, as indicated by its risk assessment. The key flag of negative net cash after subtracting total debt suggests potential liquidity constraints. The dilution risk is low, but the company's capital structure could be affected by future financing needs. The risk assessment does not indicate any significant dilution potential, but the company's financial flexibility is limited by its current liquidity position. Recent events include the publication of the 2023 annual report, which provides detailed financial and operational data. The report highlights the company's focus on maintaining financial stability and managing its aged care and health services. No significant regulatory or legal events were disclosed in the latest filings, but the company's operations are subject to the healthcare and aged care regulatory environment in Australia.

30-day price · AYUPA-4.24 (-6.3%)
Low$62.00High$67.80Close$62.61As of15 May, 00:00 UTC
Profile
CompanyAustralian Unity Ltd
TickerAYUPA.AX
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryHealthcare Facilities & Services
AI analysis

Business. Australian Unity Limited provides health, wealth, and care services, including health and life insurance, investments, banking, and aged care, primarily in Australia.

Classification. Australian Unity is classified under the Healthcare sector, specifically in the Healthcare Services & Equipment business sector, with a confidence level of 0.92.

Australian Unity has a market capitalization of $485.54 million and a price-to-earnings ratio of 18.28, indicating a moderate valuation relative to its earnings. The company's price-to-book ratio is 0.39, suggesting that its market value is significantly lower than its book value. The enterprise value to EBITDA ratio is 3.46, which is relatively low compared to industry norms, potentially indicating undervaluation or weak earnings power. In terms of profitability, Australian Unity's return on equity is 2.14%, and its return on assets is 0.25%, both of which are below the industry median for healthcare facilities and services. The company's operating income is $188.16 million, but its net income is only $26.56 million, indicating high operating expenses or significant non-operating costs. The debt-to-equity ratio is 0.54, which is relatively low, suggesting a conservative capital structure. The company's revenue is distributed across four segments: Home Health, Insurances, Residential Aged Care, and Wealth & Capital Markets. The Home Health segment provides home care and health services, while the Insurances segment offers private health insurance and distributes general insurance products. The Residential Aged Care segment owns and operates aged care facilities, and the Wealth & Capital Markets segment manages investment funds and provides trustee services. The geographic exposure is primarily within Australia, with no significant international operations disclosed. Australian Unity's growth trajectory is modest, with no significant revenue growth reported in the latest financial period. The company's capital expenditure is negative at $83.58 million, indicating asset disposals or a reduction in capital spending. The free cash flow is also negative at $6.74 million, suggesting that the company is not generating sufficient cash from operations to cover its capital expenditures. The outlook for the next fiscal year is uncertain, with no clear direction provided in the financial data. The company faces medium liquidity risk, as indicated by its risk assessment. The key flag of negative net cash after subtracting total debt suggests potential liquidity constraints. The dilution risk is low, but the company's capital structure could be affected by future financing needs. The risk assessment does not indicate any significant dilution potential, but the company's financial flexibility is limited by its current liquidity position. Recent events include the publication of the 2023 annual report, which provides detailed financial and operational data. The report highlights the company's focus on maintaining financial stability and managing its aged care and health services. No significant regulatory or legal events were disclosed in the latest filings, but the company's operations are subject to the healthcare and aged care regulatory environment in Australia.
Key takeaways
  • Australian Unity has a low price-to-book ratio, indicating a market value significantly below its book value.
  • The company's return on equity and return on assets are below industry medians, suggesting weak profitability.
  • The company's capital structure is conservative, with a debt-to-equity ratio of 0.54.
  • Australian Unity's free cash flow is negative, indicating insufficient cash generation to cover capital expenditures.
  • The company's liquidity risk is medium, with a key flag of negative net cash after subtracting total debt.
  • The company's growth trajectory is modest, with no significant revenue growth reported in the latest financial period.
  • --
  • # RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyAUD
Revenue
Gross profit
Operating income$188.2M
Net income$26.6M
R&D
SG&A
D&A
SBC
Operating cash flow$106.5M
CapEx-$83.6M
Free cash flow-$6.7M
Total assets$10.50B
Total liabilities$9.26B
Total equity$1.24B
Cash & equivalents$507.7M
Long-term debt$673.8M
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$63.11
Market cap$485.5M
Enterprise value$651.6M
P/E18.3
Reported non-GAAP P/E
EV/Revenue
EV/Op income3.5
EV/OCF6.1
P/B0.4
P/Tangible book0.4
Tangible book$1.24B
Net cash-$166.0M
Current ratio
Debt/Equity0.5
ROA0.2%
ROE2.1%
Cash conversion4.0%
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Biotechnology · cohort 9 companies
MetricAYUPAActivity
Op margin11.5% medp25 9.9% · p75 15.0%
Net margin8.6% medp25 6.3% · p75 12.4%
Gross margin28.8% medp25 28.8% · p75 28.8%
CapEx / revenue4.2% medp25 3.8% · p75 4.2%
Debt / equity54.0%71.3% medp25 60.7% · p75 71.3%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-07 10:14 UTC#0e6c52ba
Market quoteclose AUD 63.11 · shares 0.01B diluted
no public URL
2026-05-04 11:36 UTC#5151a736
Source: analysis-pipeline (hybrid)Generated: 2026-05-04 11:38 UTCJob: 1a37a2ec